| Effects of antibiotics on Shiga toxin 2 production and bacteriophage induction by epidemic Escherichia coli O104: H4 strain M Bielaszewska, EA Idelevich, W Zhang, A Bauwens, F Schaumburg, ... Antimicrobial agents and chemotherapy 56 (6), 3277-3282, 2012 | 242 | 2012 |
| Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus K Becker, S van Alen, EA Idelevich, N Schleimer, J Seggewiß, ... Emerging infectious diseases 24 (2), 242, 2018 | 240 | 2018 |
| Rapid identification of microorganisms from positive blood cultures by MALDI-TOF mass spectrometry subsequent to very short-term incubation on solid medium EA Idelevich, I Schüle, B Grünastel, J Wüllenweber, G Peters, K Becker Clinical Microbiology and Infection 20 (10), 1001-1006, 2014 | 176 | 2014 |
| Bloodstream infections–Standard and progress in pathogen diagnostics B Lamy, M Sundqvist, EA Idelevich Clinical Microbiology and Infection 26 (2), 142-150, 2020 | 133 | 2020 |
| Rapid detection of antibiotic resistance by MALDI-TOF mass spectrometry using a novel direct-on-target microdroplet growth assay EA Idelevich, K Sparbier, M Kostrzewa, K Becker Clinical Microbiology and Infection 24 (7), 738-743, 2018 | 125 | 2018 |
| How to accelerate antimicrobial susceptibility testing EA Idelevich, K Becker Clinical microbiology and infection 25 (11), 1347-1355, 2019 | 103 | 2019 |
| Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2 EA Idelevich, CM Grunewald, J Wüllenweber, K Becker PloS one 9 (12), e114834, 2014 | 80 | 2014 |
| Human MRSA isolates with novel genetic homolog, Germany A Kriegeskorte, B Ballhausen, EA Idelevich, R Köck, AW Friedrich, ... Emerging infectious diseases 18 (6), 1016, 2012 | 75 | 2012 |
| Rapid direct susceptibility testing from positive blood cultures by the matrix-assisted laser desorption ionization–time of flight mass spectrometry-based direct-on-target … EA Idelevich, LM Storck, K Sparbier, O Drews, M Kostrzewa, K Becker Journal of clinical microbiology 56 (10), 10.1128/jcm. 00913-18, 2018 | 68 | 2018 |
| Detection of mecA- and mecC-Positive Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates by the New Xpert MRSA Gen 3 PCR Assay K Becker, O Denis, S Roisin, A Mellmann, EA Idelevich, D Knaack, ... Journal of Clinical Microbiology 54 (1), 180-184, 2016 | 68 | 2016 |
| Rapid detection of extended-spectrum β-lactamases (ESBL) and AmpC β-lactamases in Enterobacterales: development of a screening panel using the MALDI-TOF MS-based direct-on … CL Correa-Martínez, EA Idelevich, K Sparbier, M Kostrzewa, K Becker Frontiers in microbiology 10, 427260, 2019 | 67 | 2019 |
| ESCMID Study Group for Bloodstream Infections, Endocarditis and Sepsis (ESGBIES). Bloodstream infections-Standard and progress in pathogen diagnostics B Lamy, M Sundqvist, EA Idelevich Clin Microbiol Infect 26 (2), 142-150, 2020 | 60 | 2020 |
| Microbiological diagnostics of bloodstream infections in Europe—an ESGBIES survey EA Idelevich, H Seifert, M Sundqvist, L Scudeller, S Amit, A Balode, ... Clinical Microbiology and Infection 25 (11), 1399-1407, 2019 | 51 | 2019 |
| Missense mutations of PBP2a are associated with reduced susceptibility to ceftaroline and ceftobiprole in African MRSA F Schaumburg, G Peters, A Alabi, K Becker, EA Idelevich Journal of Antimicrobial Chemotherapy 71 (1), 41-44, 2016 | 51 | 2016 |
| In Vitro Activity against Staphylococcus aureus of a Novel Antimicrobial Agent, PRF-119, a Recombinant Chimeric Bacteriophage Endolysin EA Idelevich, C Von Eiff, AW Friedrich, D Iannelli, G Xia, G Peters, ... Antimicrobial agents and chemotherapy 55 (9), 4416-4419, 2011 | 51 | 2011 |
| Increased prevalence and resistance of important pathogens recovered from respiratory specimens of cystic fibrosis patients during a decade L Raidt, EA Idelevich, A Dübbers, P Küster, P Drevinek, G Peters, BC Kahl The Pediatric infectious disease journal 34 (7), 700-705, 2015 | 49 | 2015 |
| Implementation of short incubation MALDI-TOF MS identification from positive blood cultures in routine diagnostics and effects on empiric antimicrobial therapy R Köck, J Wüllenweber, D Horn, C Lanckohr, K Becker, EA Idelevich Antimicrobial Resistance & Infection Control 6, 1-7, 2017 | 45 | 2017 |
| Acceleration of antimicrobial susceptibility testing of positive blood cultures by inoculation of Vitek 2 cards with briefly incubated solid medium cultures EA Idelevich, I Schüle, B Grünastel, J Wüllenweber, G Peters, K Becker Journal of clinical microbiology 52 (11), 4058-4062, 2014 | 45 | 2014 |
| Current pharmacotherapeutic concepts for the treatment of obesity in adults E Idelevich, W Kirch, C Schindler Therapeutic Advances in Cardiovascular Disease 3 (1), 75-90, 2009 | 44 | 2009 |
| Comparison of Different Phenotypic Approaches To Screen and Detect mecC-Harboring Methicillin-Resistant Staphylococcus aureus A Kriegeskorte, EA Idelevich, A Schlattmann, F Layer, B Strommenger, ... Journal of clinical microbiology 56 (1), 10.1128/jcm. 00826-17, 2018 | 41 | 2018 |
